1-8 of 8
Fausto Loberiza, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Julie M. Vose, MD, John C. Chan, MD, Philip J. Bierman, MD, Alejandro Arevalo, MD, Fausto Loberiza, MD, Kai Fu, MD, Dennis Weisenburger, MD, Robert G. Bociek, MD, Martin Bast, BS, James O. Armitage, MD
Journal: Blood
Blood (2007) 110 (11): 3430.
https://doi.org/10.1182/blood.V110.11.3430.3430
Published: 2007
Journal Articles

Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.

Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Fausto Loberiza, MD, Martin Bast, BS, Dennis D. Weisenburger, MD, James Olen Armitage, MD
Journal: Blood
Blood (2007) 110 (11): 3451.
https://doi.org/10.1182/blood.V110.11.3451.3451
Published: 2007
Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

John D. Dickinson, MD, PhD, Fausto Loberiza, MD, Victoria Whalen, Philip J. Bierman, MD, Julie M. Vose, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, James O. Armitage, MD, Greg Bociek, MD
Journal: Blood
Blood (2007) 110 (11): 3045.
https://doi.org/10.1182/blood.V110.11.3045.3045
Published: 2007
Journal Articles

High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Lymphocyte Predominant Hodgkin’s Disease.

Philip Bierman, MD, Hina Naushad, MD, Fausto Loberiza, MD, R. Gregory Bociek, MD, Julie M. Vose, MD, James Olen Armitage, MD, Patricia Aoun, MD
Journal: Blood
Blood (2006) 108 (11): 3061.
https://doi.org/10.1182/blood.V108.11.3061.3061
Published: 2006
Journal Articles

Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma.

Philip Bierman, MD, Fausto Loberiza, MD, Bhavana Dave, PhD, Warren Sanger, PhD, R. Gregory Bociek, MD, Martin Bast, BS, Julie M. Vose, MD, James Olen Armitage, MD, Dennis Weisenburger, MD
Journal: Blood
Blood (2006) 108 (11): 2030.
https://doi.org/10.1182/blood.V108.11.2030.2030
Published: 2006
Journal Articles

Outcomes Following Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with or without Advanced Care Planning.

Apar Kishor Ganti, MD, Stephanie J. Lee, MD, MPH, James O. Armitage, MD, Philip J. Bierman, MD, Gregory Bociek, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Elizabeth C. Reed, MD, Julie M. Vose, MD, Fausto Loberiza, MD, MS
Journal: Blood
Blood (2005) 106 (11): 2025.
https://doi.org/10.1182/blood.V106.11.2025.2025
Published: 2005
Journal Articles

Low Dose Alemtuzumab (Campath 1H) Prior to Allogeneic Stem Cell Transplantation Is Associated with Low Incidence of Acute and Chronic GVHD but Protracted Immune Recovery.

Marcel P. Devetten, MD, Fausto Loberiza, MD, Robin Weisenborn, MT CCRC, Pam Bunner, MT CCRC, Jamie Brewer, Solveig Ericson, MD
Journal: Blood
Blood (2005) 106 (11): 5376.
https://doi.org/10.1182/blood.V106.11.5376.5376
Published: 2005
Journal Articles

Impact of Prior Pregnancy on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.

Alison Wakoff Loren, MD, MSCE, Greta R. Bunin, PhD, Christian Boudreau, PhD, Richard E. Champlin, MD, Avital Cnaan, PhD, Mary Horowitz, MD, MS, Fausto Loberiza, MD, MS, David L. Porter, MD
Journal: Blood
Blood (2004) 104 (11): 1638.
https://doi.org/10.1182/blood.V104.11.1638.1638
Published: 2004